Pakistan unit of British firm Haleon to manufacture Centrum multivitamins

Haleon Pakistan plans to start manufacturing multivitamin brand Centrum in the country for domestic sales and export, its chief executive officer (CEO) said, as it seeks to boost sales in the country amid lower inflation. The Pakistan unit of British consumer healthcare firm Haleon plans to expand its pain management offerings next year by adding the Panadol range for menstrual pain and migraines, CEO Farhan Muhammad Haroon told Reuters in an interview. “Pakistan has a Rs24 billion ($86.30 million) Vitamin Mineral Supplement market. This does not include the grey market. We already make up Rs7.5bn ($26.97m) of the market through our [vitamin] products CAC-1000 Plus and Qalsium-D,” said Haroon. “With the launch of Centrum, we plan to capture 7 to 8 per cent of the remaining market immediately, which is a sizeable portion of the category.”